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Abstract

Introduction

The adsorption of proteins on biomedical materials such as vascular grafts is important in modulating
thrombosis, one eventual cause of vascular graft failure. We have identified proteins expressed on the surfaces of retrieved vascular grafts to determine if certain proteins were present at the end stage of vascular
failure. Scanning electron microscopic analysis of protein adsorption on the surfaces of retrieved vascular
prostheses was determined using antibodies to human
blood proteins fibrinogen, fibronectin, Hageman factor
(factor XII) and factor VIII/van Willebrand Factor. The
detection of these proteins on the blood contacting
surface was evaluated by immunogold labelling with
protein A-gold beads followed by silver enhancement.
Fibronectin was the most abundant protein detected
on retrieved expanded polytetrafluoroethylene or umbilical vein grafts. Protein adsorption was disperse for
all proteins and one protein, fibronectin, was found in
great amounts on all surfaces. Proteins such as fibronectin may be important in the adhesion and activation
of platelets and leukocytes and thus contribute to the
development of thrombosis. These analyses of human
vascular grafts indicate that surface proteins can be
readily detected by our methods and thus may be useful in determination of specific proteins important in
the thrombogenicity and/or biocompatibility of cardiovascular devices.

Replacement of diseased arteries with prosthetic
vascular grafts of biological origin or synthetic substitutes is common in vascular reconstructive surgery.
However, when small diameter vessels ( < 6 mm) are
replaced with prosthetic devices such as femoral-popliteal arteries, success rates are variable [34]. The most
common problems associated with these prosthetic
devices are thrombosis, thromboembolism and infection [13, 32]. Although exact mechanisms for failure
are uncertain, it is clear that when prosthetic materials
are implanted and exposed to circulating blood, one of
the initial events to occur is the adsorption of proteins
from the blood onto the surface of the graft [2, 3, 7,
35, 36]. Following initial protein adsorption, the success or failure of the implant is determined by continued deposition of cells and matrix molecules. This
deposition eventually constitutes the pseudointima
(neointima in animals); a layer of tissue extending from
the luminal surface of the graft material to the blood
contacting surface [32, 37].
Previous studies performed in our laboratory
have determined the presence of various blood and tissue components on retrieved Dacron and expanded
polytetrafluoroethylene (ePTFE) human vascular grafts
[1 ]. In other studies, we showed, using an in-vitro
artificial recirculation system, that protein adsorption
occurs on biomaterials after exposure to flowing blood
as early as one minute and that the composition and
characteristics of the protein layer at the blood
contacting surfaces changed with time [39]. Therefore, the goal of this study was to determine the surface protein composition of vascular grafts retrieved
from patients after prolonged implantation. We hypothesize that proteins involved in blood coagulation
and cell adhesion may be present not only early but
also at later stages of graft failure.
Many methods to determine protein adsorption
have been described and include direct protein iodination, gold labelling of purified proteins with visualization of gold beads using scanning electron microscopy
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(SEM), antibody iodination, or enzyme linked immunoassays (ELISA) [4, 6-10, 11, 12, 17, 19, 20, 24, 2627, 29, 31, 35] . We have demonstrated that other
methods may be applicable to the determination of
protein adsorption such as radioimmunoassay or immunogold labelling with silver enhancement [25, 39].
The advantages of our methods are first, the ability to
detect proteins adsorbed from a complex fluid (such as
blood) to the contacting surface and second, the detection of virtually any protein provided an antibody to
the protein of interest is available. Pasquinelli et al.
[28] have used immunogold labelling with silver enhancement on tissue sections of deendothelialized
blood vessels but have used light microscopy to
evaluate protein deposition.
Figure 1. EDX analysis of the surface of a retrieved
ePTFE graft stained for fibrinogen using immunogold
labelling with silver enhancement at 0 .02 keV . AG =
silver, PD = palladium.

Materials and Methods
Human. Explanted. Prosthetic Vascular Grafts
Prosthetic vascular grafts were retrieved from
patients subsequent to graft failure and frozen at 0°C .
The grafts were shipped to the Institute of Pathology,
Case Western Reserve University, on dry ice and
stored at -70°C until use. The grafts were composed
of ePTFE or human umbilical vein (HUV). Our choice
of materials was limited to the availability of grafts.
The grafts were cut into 0.5 cm segments and
processed for protein labelling.
Protein Labelling Procedure
Ou r methods for protein labelling have been described elsewhere [25] and are a modification of previ ously described techniques [14-16, 24, 27-29, 33].
Each graft was cut into 0.5 cm segments, bisected
longitudinally, and fixed for 7 minutes in a solution
containing 0 .1 % glutaraldehyde (Grade 1, Sigma
Chemicals, St. Louis, MO) and 2% formaldehyde. The
segments were rinsed three times in phosphate buffered saline (PBS) followed by neutralization of residual
glutaraldehyde with 50 mM glycine for 20 minutes at
room temperature. The samples were then rinsed
again in PBS. Non-specific protein binding sites on the
polymers were blocked using 15 % nonfat dry milk, in
PBS, containing 2 mM sodium EDTA. Background ad sorption was further reduced by blocking endogenous
Fe receptors or adsorbed plasma immunoglobulins with
0 .02 mg/ml of unlabeled protein A from .s_. aureus,
Cowan strain (Sigma, St. Louis, MO) added to the milk
solution above. The samples were incubated in this
solution for 1 hour at 37°C . The segments were then
rinsed in PBS (three times) and incubated with one of
the following primary polyclonal antibodies ( 1 :500
dilution in PBS containing 1 % ovalbumin) for 1 hour at
37 °C: Rabbit antihuman fibronectin (lgG fraction,
Organon Technika, Cochranville, PA) and fibrinogen,
Hageman factor (factor XII), and factor Vlll/vWF antibodies (lgG fractions) prepared from crude antisera by
octanoic acid precipitation [39].
Control studies were performed in which the
primary antibody was substituted with 1 % ovalbumin
(in PBS), or antiherpes virus, or anti-alpha-fetoprotein

(Dako Corp., Santa Barbara, CA). Herpes virus and
alpha -fetoprotein would not be expected to be found
in normal adult blood . The initial (stock) concentration
of antibodies was 1Omg/ml and the specificity of each
antibody was tested by a "checkerboard" analysis in
which each antibody was reacted with polymers ad sorbed with protein from pure solutions of each protein of interest at 37°C for 1 hour. Antifibrinogen had
low cross reactiv ity with fibronectin but the other antibodies had no significant cross-reaction. The samples
were again rinsed in PBS (three times) and then fixed
overnight in 2.5% glutaraldehyde at 4°C. The next
day, the samples were placed in clean glass test
tubes, rinsed in PBS, and then treated with 50 mM
glycine as above to neutralize glutaraldehyde . The
samples were incubated with 1: 100 dilution of protein
A-gold complex using 10 nm diameter gold beads
(Janssen, Piscataway, NJ) for 1 hour at 37°C. The
samples were rinsed in PBS, and then in distilled
water, followed by silver enhancement (lntenSE BL,
Janssen , Piscataway, NJ ) according to the manufacturer's directions for light microscopy . The samples
were rinsed in distilled water, then dehydrated in increasing ethanol concentrations (30, 70, and 100%)
for 5 minutes each. This was followed by critical
point drying, using C0 2 (Balzers Union, Hudson, NH),
after which each sample was mounted on aluminum
stubs and sputter coated with palladium or gold-palladium. All specimens were examined in the secondary
electron mode using a JEOL model 840A scanning
electron microscope set at 15-25 keV accelerating
voltage. The average working distance used was approximately 22 mm. Silver enhanced gold beads were
easily identified at magnifications greater than x4000
with the bead size near 100 nm in diameter . The composition of the observed beads on the surfaces of the
specimens was confirmed to be silver by energy dispersive x-ray analysis (EDX). Photomicrographs from
these explanted grafts were analyzed for bead
distribution .
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Figure 2. Detection of protein adsorption on a retrieved human ePTFE graft removed due to graft infection.
Protein adsorption was determined as described in the methods using antibodies for: A. Control, 1 % ovalbumin in PBS. The presence of bacteria is seen but no silver beads are visualized. The pseudointima completely covers the surface. B. Fibronectin . Several cells can be seen along with an abundant amount of silver beads particularly in the acellular areas. C. Fibrinogen. A diffuse pattern is observed, similar to fibronectin but fewer beads. D. Factor Vlll/vWF. The pattern for this protein is diffuse with a few bacteria present.
Bar = 1 µm for all photomicrographs.
Results

cleate the silver enhancing reaction, the silver peak indicated on EDX represents silver deposition on colloidal gold particles.
Our silver enhanced gold labelling technique differed from other methods [28] by using a blocking
agent (protein A/milk solution) to prevent non-specific
adsorption of the primary antibodies and/or protein A-gold. The controls in our system were essential such
that non-specific binding of primary antibody could be
ruled out. The background level of our assay is shown
in Figure 2A, with virtually no beads present. Antibodies to alpha-fetoprotein, a protein not expected to
be found in normal human circulating blood and therefore not deposited on surfaces represented another
control and few beads were present (data not shown).
In contrast, when stained for fibronectin (Fig. 2B), a

By our modification of methods used for routine
immunocytochemical analysis or scanning electron microscopy, adsorbed proteins were identified on vascular grafts retrieved from humans. Rabbit antihuman
antibodies, specifically lgG fractions obtained commercially or purified in our laboratory from crude antisera, were used as primary antibodies. Protein A-gold
was used to label the primary antibodies and was subsequently silver coated using enhancing reagents as
described earlier [25, 33). Silver beads were then visualized using scanning electron microscopy at magnifications as low as x4,000. EDX analysis (Fig. 1)
showed an intense peak for silver on the surface of
the retrieved grafts. Because metal is required to nu-
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pattern of diffuse protein adsorption occurred on this
graft. A similar pattern was observed for identification
·of fibrinogen (Fig. 2C) on the same graft. However,
fewer beads were evident when labelled for fibrinogen
as compared with fibronectin. We determined that
trace proteins ( < 0.1 mg/ml) could be identified on the
retrieved grafts. Factor Vlll/vWF, a protein found in
trace amounts in blood ( 10 µg/ml), was easily
identified on this graft (Fig. 20) but again fewer beads
were found compared to the detection of fibrinogen or
fibronectin.
In another ePTFE graft (Fig. 3), the detection of
the trace protein, Hageman factor (factor XII), on the
graft surface (Fig. 3A) showed a diffuse pattern similar
to factor Vlll/vWF seen in the previous graft. The
amount of beads attributed to fibrinogen (Fig. 38) and
fibronectin (Fig. 3C) were fewer than seen in Figure 2,
but again, were distributed uniformly.
The detection of protein adsorption on a retrieved HUV graft {Fig. 4) was less than on the explanted ePTFE grafts.
Fibronectin (Fig. 4A) and
Hageman factor (Fig. 48) were observed but the number of beads was sparse.

sis, cell adhesion and cell activation including
Hageman factor, factor Vlll/vWF, fibronectin, fibrinogen, lgG, albumin, and hemoglobin. Protein A-gold
labelling with SEM revealed that proteins from human
whole blood adsorbed to surfaces in either a uniform
or patchy pattern. For example, on ePTFE after 5
minutes of in vitro recirculation, adsorbed Hageman
factor was distributed evenly on the node and fibrils.
Factor Vlll/vWF showed a similar pattern, whereas the
adsorption pattern of fibrinogen was different in that
there was a preference for the fibrils of the material
and it was multilayered, while the nodes showed less
adsorption.
In the present studies explanted human vascular
grafts adsorbed proteins in a more uniform and disperse pattern with fibronectin displaying the greatest
number of gold beads. We did not find patchy distribution of any protein and thus these studies differed
from our earlier studies with an in vitro model. However, it is important to realize that the retrieved grafts
had been implanted for long periods compared to our
short term in vitro studies. Significant accumulation of
matrix proteins such as fibronectin in the developing
pseudointima, either deposited from blood or produced
by cells, may account for the uniform pattern found in
these studies . Other proteins, such as fibrinogen,
were readily detected and other immunocytochemical
studies have shown this protein and related fibrinogen
molecules within diseased blood vessels [18). The
importance of other proteins such as Hageman factor
and factor Vlll/vWF detected on the retrieved grafts is
unclear but both Hageman factor and factor Vlll/vWF
are important proteins involved in coagulation, fibrinolysis and complement activation [30). Factor Vlll/vWF,
fibrinogen and fibronectin are important in the adhesion of platelets and leukocytes to surfaces [7, 10, 17,
21, 23, 25, 35, 39). Once activated, these cells can
release a variety of mediators that may further influence the composition of the graft [37, 38). Thus, the
proteins deposited on the retrieved grafts have implications in the activation of blood coagulation and platelet
and leukocyte adhesion and activation.
The methods used to identify proteins in this
study and developed in our previous studies are potentially useful to the study of protein adsorption on surfaces . The advantage of our method is the ability to
identify by immunologic techniques virtually any protein that adsorbs to a surface provided an antibody is
available for that specific protein. It is also an advantage to identify a specific protein (antigen) by antibody
binding to that protein in a complex solution containing
many proteins such as those found in blood . In addi tion, we controlled for the non-specific binding of antibodies to the surfaces by using antibodies to proteins
not normally found in human blood, alpha-fetoprotein
and Herpes virus. Secondly, non-specific protein binding sites on the polymer surface were blocked by the
use of non-fat dry milk. This blocking agent has been
used in immunocytochemical and immunoblotting applications [5) and we also used the milk solution with

Discussion
The development of small diameter vascular
prostheses for treatment of peripheral vascular disease
has been hampered by the occurrence of thrombosis
and other problems [13). There is a rather poor understanding of the interaction of blood with graft materials during the early and late stages of implantation.
The types of adsorbed proteins, their morphological
distribution and their interaction with cells may play a
significant role in determining the ultimate biocompatibility and/or thrombogenicity of the graft.
The use of immunological labels to study protein
adsorption on biomaterials have been used by others
[23, 26-29). Many of these studies have used single
purified proteins or combinations under static non-flow
conditions or have used non-human blood, plasma or
proteins. For example, in a series of papers, Park and
co-workers [26, 27, 29) described the use of immunologic labels to study adsorption of human and canine
blood proteins on biomaterials. Albumin, fibronectin,
and fibrinogen were visualized on polyvinylchloride,
silicon rubber, polyethylene, oxidized polyethylene,
8iomer, and Teflon. Complete coverage of these surfaces by fibrinogen occurred and to a lesser extent
with albumin. Formation of fibronectin networks on
the surfaces of polyethylene were suggestive of incomplete or altered adsorption due to intermolecular
association of proteins.
We have previously investigated short term (::::;
3 hours) blood protein adsorption using an in vitro
recirculation system [25, 39). Anticoagulated or nonanticoagulated human whole blood was circulated
through clinically relevant small diameter (4 mm) and
NHL81-DT8 reference materials. We detected the adsorption of proteins important to coagulation, fibrinoly-
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Figure 4 . Detection of protein adsorption on retrieved
human umbilical vein graft. Protein adsorption was
determined as described in the methods using anti bodies for:
A. Hageman factor (factor XII). The surface of th is
graft is different from the previous ePTFE grafts in that
no pseudointima is present. Note that the number of
beads is fewer than in the ePTFE grafts.
B. Fibronectin . There are more silver beads present
than in A. Bar = 1 µm for all photomicrographs.

Figure 3 (at left). Detection of protein adsorption on
different retrieved human ePTFE grafts removed for
graft infection. Protein adsorption was determined as
described in the methods using antibodies for:
A.
Hageman factor (factor XII). The pattern of
Hageman factor on this graft is diffuse.
B. Fibrinogen. There is an appreciable number of
silver beads comparable to the previous graft detected
with fibrinogen.
C. Fibronectin. There are fewer beads on this graft
compared to the graft in Fig. 1 B.
Bar = 1 µm for all photomicrographs .
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density lipoproteins from blood plasma onto biomaterials surfaces. Biomaterials .5_, 269-274.
9.
Chuang. HYK, Andrade JD (1985) lmmunochemical detection by specific antibody to thrombin of prothrombin conformational changes upon adsorption to artificial surfaces . J. Biomed. Mater. Res.
_ll!, 813-825.
10.
Chuang HYK ( 1984) In situ immunoradiometric assay of fibrinogen adsorbed to artificial
surfaces. J. Biomed . Mater. Res. la, 547-559.
11.
Cox DP, Schroff PD ( 1986) lmmunogold
staining reagents: A sensitive technique for biomedical
research. Am. Biotech . Lab . ,4, 18-23.
12.
de Harven E, Leung R, Christensen H
( 1984) A novel approach for scanning electron microscopy of colloidal gold-labelled cell surfaces . J. Cell
Biol. 99, 53-57.
13.
Esquivel CO, Blaisdell FW (1986) Why
small caliber vascular grafts fail: A review of clinical
and experimental experience and the significance of
the interaction of blood at the interface. J. Surg . Res .
41 , 1- 15.
14.
Goding JW ( 1978) The use of Staphylococcal protein A as an immunological reagent. J.
lmmunol. Meth. ,2, 241-253.
15.
Goodman SL, Albrecht RM (1987) Correlat ive light and electron microscopy of platelet adhe sion and fibrinogen receptor expression using colloidal gold labelling . Scanning Microsc . 1. 727-734.
16.
Goodman SL, Hodges GM, Trejdosiewicz
LK, Livingston DC ( 1979) Colloidal gold probes - a
further evaluation . Scanning Electron Microsc. 1979:
Ill, 619-628.
17 .
Grinnell F, Feld MF ( 1982) Fibronectin adsorption on hydrophilic and hydrophobic surfaces detected by antibody binding and analyzed during cell
adhesion in serum-containing medium. J. Biol. Chem.
257 , 4888-4893.
18 .
Hatton MWC, Moar SL, Richardson M
( 1989) Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface . Correlation
of uptake of fibrinogen and antithrombin Ill with
thrombin generated by the exposed subendothelium.
Am. J. Pathol. 135, 499-508.
19.
Hodges GM, Southgate J, Toulson EC
( 1987) Colloidal gold - a powerful tool in scanning
electron microscope immunocytochemistry: An overview of applications. Scanning Microsc. 1, 301-318.
20.
Horbett T ( 1989) Techniques for protein
adsorption studies. In: Techniques of Biocompatibility
Testing, vol. 2, Williams OF (ed .), CRC Press Inc.,
Boca Raton, FL, 183-214.
21.
Horbett TA, Counts RB ( 1984) von Willebrand factor/factor VIII adsorption to surfaces from
human plasma . Thromb. Res. 36, 599-608.
22.
Matsuda T, Takano T, Hayashi K,
Taenaka S, Takaichi S, Umezu M, Nakamura T, Iwata
H, Nakatani T, Tanaka T, Takatini S, Akutsu T (1984)
The blood interface with segmented polyurethanes:
"Multilayered protein passivation mechanism". Trans.

non-gold labelled protein A to prevent any additional
non-specific binding of protein A. Therefore, low
background detection of gold beads was observed .
Thirdly, the use of silver enhancement provided better
visualization of labelled proteins since beads were
enlarged from 10 nm to between 60 and 100 nm, and
easily visualized at magnifications between x2,000x 10,000. In addition, the relationship of the beads
with the surface features of the pseudointima, such as
adherent cells or matrix components, can be readily
observed.
In summary, we describe the identification of
proteins on retrieved vascular grafts in an attempt to
identify proteins on the surface that may be involved
in the failure of grafts due to thrombosis. The adsorption of proteins onto a material is an important event
that can modulate thrombotic or antithrombotic responses. Further work is necessary in understanding
the complex interaction of blood with surfaces in orde r
to desig n and develop new materials for use as card iovascular devices, prostheses or artificial organs .
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Discussion with Reviewers
Reviewer I: The protocol of freezing at 0°C, then
shipping on dry ice would produce very slow freezing.
Storing at 0°C is probably alright (since it is doubtful
that freezing would occur), but the subsequent handling would cause a great deal of ice crystal damage
as the crystallization front migrated across the sample.
Following such a protocol I would not expect the morphology of the sample to be representative of it in life.
R.M. Albrecht: Do the slow freezing procedures employed have effects on structure or antigenicity due to
large crystal size and/or solute concentrations and pos sibly selective dehydration during freezing?
Authors: We have other evidence to address the con cern regarding potential freezing artifacts during specimen handling. An ePTFE vascular graft (4 mm diameter) was exposed to whole human blood, with n0-.
anticoagulant, for one minute. The graft was then cut
into 1 cm segments and one half of these segments
were frozen at 0°C for two days (slow freezing) . The
remaining segments (fresh samples) were subjected to
the protein detection methods described in this paper
and fibrinogen (FB), fibronectin (FN), factor Vlll/vWF
(F-Vlll), and Hageman factor (HF) were detected.
Alpha-fetoprotein and ovalbumin were used as controls
as described in the manuscript . The frozen segments
were thawed at room temperature and subjected to
the same procedure. SEM was then used to visualize
the silver enhanced goid beads on both the frozen and
fresh samples. The beads were counted and expressed as the number of beads per cm 2 • These values were then plotted against each other and a correlation coefficient (R value) of 0.995 was determined
(see Table 1 and Fig. 5).
These data suggest that the potential for artifact
as a result of freezing the explanted vascular grafts
was minimal. The slow freezing method may affect
structures on the surface but this was not the main
goal of the study, rather it was to study protein adsorption patterns. The extent to which freezing affects antigenicity of proteins is unknown but it may
have less effects than other preservation methods
such as glutaraldehyde or paraformaldehyde.
Reviewer I: What was done to ensure that plasma
proteins were not adsorbed after retrieval? Was the
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tect cross-reacting antibodies from the general milieu.
The only purpose of this analysis was to obtain reasonably convincing evidence, but not necessarily
proof, that our antibodies did not cross-react with
other prot eins of interest. While glutaraldehyde may
alter the antigenicity of the protein in question, we
would expect that this systematic error would hold
true in the checkerboard analysis since these samples
were treated the same way .
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Reviewer I: With silver enhanced gold technique each
and every gold label is not enhanced or enhanced
evenly . This can make it difficult to determine, especially, the relative levels of labelling on different samples. Why not use gold labels large enough to be detectable in the SEM without silver enhancement (e.g. ,
20-50 nm gold)?
R.M. Albrecht: In the present case of surface labelling, is t here evidence to suggest that the efficiency of
labelling is better with the smaller probe diameters,
i. e., 5 to 10 nm? If not, might it be more expedient to
simply label with a larger, 20 to 40 nm, probe size and
avoid problems of variable levels of enhancement inherent in the silver process? Would direct conjugation of
the label t o the primary antibody be more useful than
indirect labelling for quantitative studies? Do the au thors have any experience to suggest directly conjugated probes have reduced or increased labelling
effic iency ?
Authors: Early studies showed that increasing the
bead size decreased the labelling specificity, probably
due to stearic hindrance of protein-A gold/antibody
binding . In addition, 20-50 nm gold beads are harder
to visualize using SEM than 100 nm silver enhanced
beads . The silver enhancement process allows for
greater specificity and improved visualization of the
label. This is valid and perhaps future work should address this question directly. Performing these studies
with only a single antibody step with a larger bead
would have the possible advantage that it would avoid
a second antibody and its associated binding uncertainties. One disadvantage is that more antibodies
would have to be gold-labelled. We do not have any
direct experience in this regard but we would expect
that directly conjugated probes would have decreased
binding efficiency from stearic hindrance and possibly
from antibody conformational changes. This is generally thought to be true with tissue immunocytochemistry.
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Figure 5. Comparison of fresh versus frozen tech niques on protein adsorption of ePTFE grafts.
Table 1. Quantification of Silver Enhanced Gold Beads
Each value is expressed as the number of beads x
7
10 /cm 2 . The error expressed is a counting error .
FB

FN

F-Vlll
/vWF

HF

Oval

AP

Fresh

194 ± 20 50 ± 10 82 ± 10 22 ± 2 2 ± 2

2±2

Frozen

180±20 54±10 76±10 32±2 2±2

2±2

preparation rinsed after explantation?
Authors: Since these were long term implants, we
would not expect the composition of the adsorbed protein layer to change significantly even if there was residual plasma in the lumen upon removal. We could
not control rinsing at the operation site so we cannot
address the issue of specimen handling prior to
shipment.
Reviewer I: In the "checkerboard" assay, was adsorption measured onto the same materials, i.e ., ePTFE
and HUV? Is only 1 hour adsorption really relevant for
this assay since proteins continue to denature for
several hours, if not days, following adsorption? Were
these samples also treated with glutaraldehyde? The
glutaraldehyde will alter protein antigenicity and thus
affect labelling.
Authors: The purpose of the checkerboard analysis
was not to mimic the in-vivo adsorption of proteins
but to test our antibodies for cross-reactivity. Ideally,
this kind of test would simulate precisely the in-vivo
situation, but we could not do that and be able to de-

Reviewer I: Could not differences in the denaturation
of protein after adsorption, in the short term in-vitro
versus the long term implantation, affect these
results?
Authors: We would certainly expect long-term degradation of adsorbed protein to partially affect these results. That is the reason for undertaking this study, so
that comparisons can be made with similar experiments w ith no long term degradation (in-vitro studies).
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comes important. These factors may have a deleterious effect on protein antigenicity. Different epitopes
have different sensitivities. Thus if one is to label
subsequently and compare relative amounts of label,
it is essential that some sort of control (i.e., unfrozenfixed, unfixed, or ultra rapidly frozen/rapidly thawed)
must be done to ensure that the loss of antigenicity
does not affect the estimates of one surface bound
component relative to another. The problem is generally more severe when dealing with cell surface bound
antigens than with proteins on surfaces as is the case
here. Nevertheless, I think the controls are advisable.
Simple structural displacement due to the crystal size
also could be a problem.
Small gold probes are useful for a variety of reasons including increased accessibility, penetration, and
to provide a better quantitative estimation where density of epitope is such that a larger bead could overlap
variable numbers of sites. Smaller particles also afford
a more precise level of positional resolution.
In the present case however, it might be better
to use larger 20-40 nm probes to begin with and avoid
all the trouble of silver enhancing with its highly variable level of enhancement of individual gold particles .
I am not sure I fully appreciate the need for larger
probe size, it may be due to instrument limitations or
just that they are easier to see at low magnification
micrographs. If the latter is the case, BSE imaging
with various image processing techniques can provide
good visualizable localization without having to grow
giant labels.
Authors: Thank you for your comments.

Reviewer I: In Fig. 2a, what are the small round
spheres (about 0.5 mm on the micrograph), if they are
not "beads"? Since the size of the silver reaction
product is not easily controlled, some means other
than size must be used to determine that they are not
silver-enhanced gold. An EDX map could serve this
purpose.
Authors: The small round spheres are bacteria. Figure
1, an EDX spectrum for Hageman factor detection by
immunogold labelling with silver staining, shows that
the major reaction product is silver, although palladium
is also identified. We have performed other EDX analyses for each protein determined on these surfaces
and the data are similar in that the major peak is
always silver.
G. Pasquinelli: How many vascular grafts did you
study? Did you find any difference between ePTFE
and umbilical vein grafts?
Authors: We tested a total of 5 grafts that were suitable for this study. Minimal differences, with this
small number studied , were found between ePTFE and
HUV that we feel are convincing enough to publish.
G. Pasauinelli: You state that fibronectin was the
most abundant protein detected on your samples.
What method did you use to compare the results? Did
you perform a count on the enhanced gold particles?
Authors:
We did not count beads to compare
amounts of protein present. Visual inspection was
used to make obvious comparisons.
G. Pasquinelli: How old were the human implants? As
regards protein adsorption, is there any difference
between grafts which failed due to thrombosis or
infection?
Authors: The implants had been in place for months
to years. Our study is too small to determine differences between thrombosis and infection. More study
is definitely needed. We would expect bacteria to
degrade and modify proteins, and produce and deposit
some of their own unique, and possibly cross-reacting,
proteins on the surface.

R.M. Albrecht: Is antigenic specificity of the species
of interest retained in the face of glutaraldehyde
fixation?
Authors: By all indications in our checkerboard analysis, antigenic specificity is preserved. In order to
minimize non-specific cross-linking of antibodies to the
surface, glutaraldehyde treatment was always followed by glycine "neutralization".
R.M. Albrecht: Is it clear that the protein A used to
block the Fe fragments of non-specifically adsorbed
immunoglobulin cannot also bind Fe of subsequently
added polyclonal antibodies? Protein A has been
shown to bind Fab ends of some antibodies. Does
protein A bind equally well to all types of rabbit antibodies? Has, for example, anti-Fe-gold or anti-human
lgG-gold been used to see if Fe of plasma adsorbed lgs
are actually present in sufficient concentration to be a
problem?
Authors: We are assuming that once protein A is
bound to an Fe site on the surface, it does not subsequently migrate to another. We do not know if this is
a valid assumption. According to the manufacturer,
protein A binds "strongly" to rabbit lg. We do know
that plasma adsorbed lgs are on the surface since this
was one of our test antibodies. Since they are present
in detectable amounts, we felt a blocking step for the

G. Pasquinelli: Have you performed analogous experiments without preliminary fixation with glutaraldehyde? Did you find differences in antibody binding?
Authors: No experiments were done without preliminary fixation. This will be considered in future work.
R.M. Albrecht: The preservation and storage procedure could be a source of variability. Slow freezing of
large specimens results in extremely large ice crystals
and slowly moving freezing fronts (the temperature
listed was 0°C, but this is actually above the freezing
point of the tissue). The water activity gradients can
be relatively high with solutes concentrating along the
front and between crystals. Since considerable migration of water molecules occurs to the expanding but
lower vapor pressure ice crystal, dehydration also be-
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K. Park: One of the dangers in interpreting the colloidal gold staining is that the extent of gold staining
may not be related to the concentration of target proteins, except when the target protein is covered as a
monolayer. Since immunogold staining is also related
to the exposure of target proteins, the fewer beads on
the surface do not necessarily mean that fewer protein
molecules exist. Some proteins may be hidden by
other proteins so that they may not be detected by
immunogold staining. The authors need to reflect this
aspect of immunogold staining in their results.
Authors: While there has been much work concerning
the initial events in protein adsorption that could
determine final clinical outcome, this study looked at
the other extreme: the end point. This study does not
ask what is the composition of the pseudointima but
what is on the surface at the time of failure.

other proteins was warranted. Otherwise, there might
be increased background staining since protein A could
potentially bind to these antibodies as well.
K. Park: The authors used protein A-gold complex at
the concentration which was not described in the
manuscript. They simply diluted the 10 nm gold beads
obtained from Janssen by 100 folds. Since the concentration of the gold beads is very important in determining the staining time, the concentration should
be described. For example, it is not clear whether
staining for 1 hour at 37 °C is enough to have full
staining of the sample. How did the authors know
that staining for longer period of time is not
necessary?
Authors: Dr. Park is quite right in this point and we do
not know the precise concentration of protein A-gold
in our solution. We tried various staining times and
dilutions by trial and error, and, while we do not know
the precise optimum, this combination worked well.
More concentrated solutions seemed to consistently
give high background staining of controls while more
dilute solutions showed poor staining even for proteins
we would expect in abundance (such as albumin). Future work should look at the staining time since this
variable was not systematically examined by us. One
to two hours was a convenient amount of time but
more dilute solutions may work with lengthened
staining time.

K. Park: Protein adsorption and thromboemholism are
dynamic events. The immunogold staining data, however, represent protein adsorption profile at a particular
time point. Please comment on how this snap-shot
examination is related to the overall dynamic events?
Authors: This is related to Dr. Park's previous question. We are looking at the end point in this study.
While initial events are probably extremely important
in determining outcome, it is not known if the final
surface composition is important. This kind of study
may help to answer that question.
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